The Health Ministry will not carry out vaccination against Ebola following the outbreak in North Kivu in the Democratic Republic of Congo-DRC. A new strain of the hemorrhagic fever has already claimed more than 30 people in in North Kivu.
As a result, the DRC government is scheduled to embark on mass vaccination in the area on Wednesday using a vaccine produced by Merck. The vaccination will mainly target health workers and people who have come into contact with confirmed Ebola cases.
The Congolese Health Ministry says the vaccine have proved to be effective in North Western Congo where an Ebola outbreak was declared two weeks ago. A study carried out by Lancet Laboratories in 2016 shows that the vaccine is effective for up two years once administered.
This publication spoke to the Ugandan Health Ministry to establish its preparedness for the Ebola outbreak in DRC and whether it would also consider vaccinating people on the common border with DRC.
The districts bordering DRC include Kasese, Kisoro, Kabarole, Ntorooko and Kanunugu. Emmanuel Ainebyoona, the Public Relations Officer of the Health Ministry, says Uganda cannot use the vaccine since it hasn’t been approved for Ebola control in the country.
He however, says Uganda is on high alert following the declaration of the Ebola Outbreak in North Kivu.